Atlas Trials

A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

Clinical trial NCT03099876 · UNKNOWN

Trial details

NCT number
NCT03099876
Sponsor
Il-Yang Pharm. Co., Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Helicobacter Pylori Infection
Start date
2017-03-01
Primary completion
2017-12-01
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.